Docebo's Enterprise Momentum Looks Real, but the Market Already Priced It In
Docebo Inc (DCBO) reports second-quarter 2026 earnings tomorrow before market open, with the stock trading at $20.48 and analysts expecting $0.17 per share. The learning management software provider faces a critical test as Wall Street watches for signs of sustained profitability and revenue acceleration after a mixed first quarter that saw a modest earnings beat but revenue shortfall.
Part 1: Earnings Preview
Docebo Inc provides cloud-based learning management software (LMS) that helps enterprises deliver training and development programs at scale. The company serves a global customer base across multiple industries, positioning itself as a leader in the corporate e-learning market.
Docebo reports second-quarter 2026 earnings on August 7, 2026, before market open. The consensus estimate stands at $0.17 per share, with only one analyst covering the quarter. The company most recently reported $0.30 per share for Q1 2026, beating the $0.29 estimate by 3.45%. Year-over-year, the current estimate represents a 29.17% decline from the $0.24 reported in Q2 2025, raising questions about near-term profitability trends.
Three key themes define this earnings story:
Revenue Growth Trajectory: Investors are watching whether Docebo can maintain double-digit revenue growth amid increasing competition in the LMS space. Web search data suggests analysts expect Q2 revenue around $69.34 million, representing approximately 14% year-over-year growth, though the company missed revenue estimates last quarter.
Profitability and Margin Expansion: The sharp sequential decline in EPS estimates—from $0.30 in Q1 to $0.17 in Q2—has raised concerns about margin pressure and operating leverage. Analysts are looking for commentary on cost management and the path back to stronger earnings growth, particularly as the full-year 2026 estimate of $1.39 implies significant acceleration in the second half.
Customer Acquisition and Retention Metrics: With 12 analysts maintaining a consensus Buy rating and an average price target of $28.68 (40% upside from current levels), the bull case hinges on Docebo's ability to demonstrate strong customer growth and net retention rates that support its premium valuation in the SaaS sector.
Analyst commentary ahead of the release reflects cautious optimism. The consensus has shifted notably, with the Q2 estimate revised down from $0.24 to $0.17 over recent months, suggesting analysts have tempered near-term expectations. However, the strong Buy-rated consensus and elevated price targets indicate confidence in the company's longer-term growth story, with analysts projecting 22.30% EPS growth in 2027.
Part 2: Historical Earnings Performance
Docebo has demonstrated a volatile but generally positive earnings track record over the past four quarters. The company has beaten EPS estimates in three of the last four quarters, with particularly strong outperformance in Q2 2025 (+50.00%) and Q4 2025 (+46.43%). The most recent quarter (Q1 2026) delivered a modest beat of 3.45%, reporting $0.30 versus the $0.29 estimate.
The pattern reveals significant variability in both results and estimate accuracy. While Q2 and Q4 2025 saw substantial beats, Q3 2025 produced a small miss of -3.57%. The magnitude of surprises has been considerable, ranging from -3.57% to +50.00%, suggesting analysts have struggled to model the business consistently. Reported EPS has ranged from $0.24 to $0.41 over this period, showing meaningful quarterly fluctuation.
The trend appears to be moderating after the exceptional Q4 2025 performance. The Q1 2026 result of $0.30 represented a sequential decline from $0.41, and the current Q2 estimate of $0.17 implies further near-term pressure. This deceleration contrasts with the strong beats earlier in the cycle, potentially reflecting either tougher comps, margin compression, or more conservative analyst positioning after previous misses.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $0.16 | $0.24 | +50.00% | Beat |
| Sep 2025 | $0.28 | $0.27 | -3.57% | Miss |
| Dec 2025 | $0.28 | $0.41 | +46.43% | Beat |
| Mar 2026 | $0.29 | $0.30 | +3.45% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Docebo typically reports earnings before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-08 | +$0.24 (+1.15%) | $2.16 (10.31%) | -$2.07 (-9.76%) | $2.05 (9.67%) |
| 2026-02-27 | -$0.53 (-2.96%) | $1.49 (8.32%) | +$0.26 (+1.50%) | $0.86 (4.95%) |
| 2025-11-07 | -$0.88 (-3.61%) | $2.62 (10.76%) | +$0.13 (+0.55%) | $0.71 (3.05%) |
| 2025-08-08 | +$1.48 (+5.09%) | $3.05 (10.49%) | +$0.60 (+1.95%) | $2.37 (7.76%) |
| 2025-05-09 | -$5.43 (-16.95%) | $7.38 (23.04%) | -$0.75 (-2.82%) | $1.58 (5.94%) |
| 2025-02-28 | -$5.24 (-14.04%) | $7.93 (21.24%) | +$0.93 (+2.90%) | $1.73 (5.39%) |
| 2024-11-08 | +$0.27 (+0.53%) | $3.45 (6.74%) | -$1.31 (-2.55%) | $1.71 (3.32%) |
| 2024-08-08 | +$5.24 (+14.36%) | $4.51 (12.36%) | +$0.05 (+0.12%) | $2.66 (6.37%) |
| Avg Abs Move | 7.33% | 12.91% | 2.77% | 5.81% |
Historical price action around Docebo earnings has been highly volatile with an average absolute Day 0 move of 7.33% and average intraday range of 12.91%. The stock has shown dramatic swings, particularly in early 2025 when it posted consecutive double-digit declines of -16.95% (May 2025) and -14.04% (February 2025) on earnings day. More recently, volatility has moderated but remains elevated, with the most recent report (May 2026) producing a 1.15% gain on Day 0 but a sharp -9.76% reversal on Day +1.
The Day +1 follow-through averages 2.77% with a 5.81% range, suggesting continued volatility into the second session. Notably, the direction of Day 0 and Day +1 moves has been inconsistent—the stock can rally initially then reverse sharply (as in May 2026) or decline on results then recover (as in February 2026). The most recent earnings cycle shows this unpredictability, with a modest Day 0 gain followed by a significant next-day selloff despite beating estimates.
Investors should prepare for substantial price movement, as six of the last eight reports produced Day 0 moves exceeding 5%, and four exceeded 10%. The stock's tendency toward large intraday ranges (averaging nearly 13%) suggests options premiums will be elevated and directional bets carry significant risk.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 15) |
| Expected Move | $2.13 (10.41%) |
| Expected Range | $18.30 to $22.55 |
| Implied Volatility | 92.71% |
The options market is pricing a 10.41% expected move for the August 21 expiration, implying a range of $18.30 to $22.55. This is notably higher than the 7.33% average historical Day 0 move but below the 12.91% average intraday range, suggesting options traders are pricing in above-average volatility but not the extreme moves seen in early 2025. The elevated implied volatility of 92.71% reflects continued uncertainty around the company's near-term trajectory.
Part 3: What Analysts Are Saying
Analysts maintain a bullish stance on Docebo with an average rating of 4.33 out of 5.0 (Buy territory) and a mean price target of $28.68, implying 40% upside from the current price of $20.48. The consensus includes 8 Strong Buy ratings, 2 Moderate Buy ratings, 1 Hold, and 1 Strong Sell, reflecting broad but not unanimous optimism about the stock's prospects.
The sentiment trend has deteriorated over the past month, with the average recommendation slipping from 4.38 to 4.33. This modest decline reflects a shift in the rating distribution: one analyst downgraded from Hold to Strong Sell, while the number of Hold ratings decreased from 3 to 1. Despite this recent softening, the overwhelming majority of analysts (10 of 12) maintain Buy or Strong Buy ratings, indicating the Street's conviction in the long-term story remains intact.
The price target range is wide, spanning from a low of $22.00 to a high of $38.00, suggesting meaningful disagreement about valuation and growth trajectory. The $22.00 floor implies just 7% upside, while the $38.00 bull case represents 86% potential appreciation. This dispersion likely reflects differing views on Docebo's ability to reaccelerate earnings growth and expand margins after the recent deceleration. The mean target of $28.68 sits comfortably in the middle, suggesting the consensus view balances near-term execution concerns against longer-term SaaS growth potential.
Part 4: Technical Picture
The Barchart Technical Opinion currently shows a 56% Buy signal, representing a significant improvement from the 40% Sell signal just one month ago and the 40% Buy reading one week ago. This strengthening technical picture suggests momentum has shifted in favor of the bulls heading into the earnings release.
Timeframe Analysis:
- Short-term (100% Buy): Strong buy signal indicates near-term momentum is decidedly positive, with the stock showing strength over the immediate trading horizon
- Medium-term (Hold): Neutral reading suggests the intermediate-term trend remains in consolidation mode without clear directional conviction
- Long-term (50% Buy): Moderate buy signal reflects cautiously positive sentiment in the longer-term trend structure
Trend Characteristics: The trend is characterized as Weak strength with Average direction, suggesting the recent improvement in technical signals lacks robust conviction and the directional bias remains moderate rather than decisive heading into earnings.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $20.63 | 50-Day MA | $18.63 |
| 10-Day MA | $20.65 | 100-Day MA | $18.33 |
| 20-Day MA | $19.82 | 200-Day MA | $19.77 |
The stock is trading at $20.48, positioned above its 20-day ($19.82), 50-day ($18.63), and 100-day ($18.33) moving averages, but below its 5-day ($20.63) and 10-day ($20.65) moving averages. The stock sits just above its 200-day moving average of $19.77, suggesting it has reclaimed longer-term support after recent weakness. This mixed moving average picture—above intermediate and long-term averages but below very short-term levels—indicates the stock has built a constructive base but faces near-term resistance. The technical setup is cautiously supportive heading into earnings, with the stock holding above key support levels but lacking the momentum of a strong uptrend. The 10.41% options-implied move suggests traders should be prepared for significant volatility, and a break above the $20.65 level (10-day MA) on strong results could open the door to the $22.55 upper range, while a disappointment could test support at the 20-day MA near $19.82.